BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

IXJvsPBPHETF Comparison

ETF 1

IXJ

iShares Global Healthcare ETF

This fund is part of

Global Large Cap

-0.8%

Full IXJ fund page

VS

ETF 2

PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of

DM Large & Mid Cap

-0.7%

Full PBPH fund page

iShares Global Healthcare ETF (IXJ) belongs to the Global Large Cap segment. Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is part of the DM Large & Mid Cap segment. IXJ's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Consumer Cyclicals. In contrast, PBPH's top sector exposures are Healthcare. IXJ is more expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.13% for PBPH. IXJ is up 6.01% year-to-date (YTD) with -$505M in YTD flows. PBPH performs better with 11.66% YTD performance, and +$968M in YTD flows. Run a side-by-side ETF comparison of IXJ and PBPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

IXJ vs PBPH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 09/14/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	IXJ PBPH	-0.13%+1.74%	+7.90%+9.54%	+6.01%+11.66%	+18.74%n/a	+25.39%n/a	+26.74%n/a
Flows	IXJ PBPH	-+$35M	+$233M+$139M	-$505M+$968M	-$256M-	-$567M-	+$23M-

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	IXJ PBPH	+18.65%+20.72%	+15.82%n/a	+14.26%n/a	+14.56%n/a
Max drawdown	IXJ PBPH	-6.30%-6.59%	-10.83%n/a	-18.04%n/a	-18.04%n/a
Max drawdown duration	IXJ PBPH	20d20d	122dn/a	490dn/a	490dn/a

Trading data

Create an account to view trading data

Join for free

	IXJ	PBPH
Last sale 9/15/2026 at 1:30 PM	$102.16	$28.11
Previous close 09/14/2026	$102.27	$28.22
Consolidated volume 09/14/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of August 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	IXJ	PBPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 9/15/2026 at 1:30 PM

Live

Closed

	IXJ	PBPH
Last price	$102.16	$28.11
1D performance	-0.11%	-0.38%
AuM	$4.20 B	$1.02 B
E/R	0.38%	0.13%

Characteristics

	IXJ	PBPH
Management strategy	Passive	Passive
Provider	iShares	Tidal
Benchmark	S&P Global 1200 Health Care (Sector) Capped Index	BITA Global Pharma and Biotech Select Index
N° of holdings	110	52
Asset class	-	-
Trailing 12m distribution yield	Join	Join
Inception date	November 13, 2001	November 24, 2025
ESG	No	No

More IXJ data on Trackinsight

More PBPH data on Trackinsight

Exposure

Countries

IXJ

USA

69.7%

Switzerland

10.39%

Other

19.91%

PBPH

USA

65.24%

Switzerland

10.52%

United Kingdom

7.15%

Other

17.09%

Sectors

IXJ

Healthcare

97.09%

Other

2.91%

PBPH

Healthcare

99.46%

Other

0.54%

Diversification

IXJ

Total weight of top 15 holdings out of 15

56.91%

PBPH

Total weight of top 15 holdings out of 15

75.4%

Top 15 holdings

Data as of July 31, 2026

IXJ

Eli Lilly & Co.

10.27%

Johnson & Johnson

6.92%

AbbVie, Inc.

5.11%

UnitedHealth Group, Inc.

4.35%

Merck & Co., Inc.

4.06%

Roche Holding AG

3.89%

Novartis AG

3.64%

AstraZeneca PLC

3.35%

Thermo Fisher Scientific, Inc.

2.71%

Amgen, Inc.

2.65%

Abbott Laboratories

2.33%

Gilead Sciences, Inc.

2.06%

Novo Nordisk A/S

2.05%

Pfizer Inc.

1.80%

CVS Health Corp.

1.70%

PBPH

Eli Lilly & Co.

15.14%

Johnson & Johnson

9.55%

AbbVie, Inc.

7.06%

Merck & Co., Inc.

4.97%

Roche Holding AG

4.70%

Amgen, Inc.

4.62%

Novartis AG

4.45%

AstraZeneca PLC

3.88%

Gilead Sciences, Inc.

3.77%

Novo Nordisk A/S

3.75%

Pfizer Inc.

3.28%

Bristol Myers Squibb Co.

3.06%

Vertex Pharmaceuticals, Inc.

2.82%

GSK Plc

2.24%

Sanofi

2.10%

Frequently asked questions about IXJ and PBPH

How have the IXJ and PBPH ETFs performed in 2026?

As of September 14, 2026, IXJ is up 6.01% year-to-date (YTD), while PBPH has returned 11.66%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: IXJ or PBPH?

Year-to-date, the IXJ ETF saw -$505M in flows, compared to +$968M for PBPH.

Which ETF is bigger: IXJ or PBPH?

As of September 14, 2026, IXJ holds $4.20 B in assets under management (AUM), while PBPH manages $1.02 B.

What sectors do the IXJ and PBPH ETFs invest in?

IXJ leans toward sectors like Healthcare. Meanwhile, PBPH focuses on Healthcare.

What are the top holdings of the IXJ ETF and PBPH ETF?

IXJ top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. PBPH holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

IXJvsPBPHETF Comparison

iShares Global Healthcare ETF

Portfolio Building Block World Pharma and Biotech Index ETF

IXJ vs PBPH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the IXJ and PBPH ETFs performed in 2026?

As of September 14, 2026, IXJ is up 6.01% year-to-date (YTD), while PBPH has returned 11.66%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: IXJ or PBPH?

Year-to-date, the IXJ ETF saw -$505M in flows, compared to +$968M for PBPH.

Which ETF is bigger: IXJ or PBPH?

As of September 14, 2026, IXJ holds $4.20 B in assets under management (AUM), while PBPH manages $1.02 B.

What sectors do the IXJ and PBPH ETFs invest in?

IXJ leans toward sectors like Healthcare. Meanwhile, PBPH focuses on Healthcare.

What are the top holdings of the IXJ ETF and PBPH ETF?

IXJ top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. PBPH holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: IXJ or PBPH?

IXJ holds 111 securities with 56.91% of its assets in the top 15. PBPH has 53 securities and a top 15 weight of 75.4%.

Healthcare Funds on the Rise

Healthcare Stocks Rebound

Continued tightening of the U.S. labor market

Build and Analyze Your ETF Portfolio Like a Pro